EPA 2016

blog image

EPA 2016

m-RESIST will be presented during the Symposium “Lifespan development of schizophrenia and how the treatments improve outcome”, chaired by Professor emeritus Matti Isohanni (Finland) during the European Congress of Psychiatry (EPA 2016), that will be held on 12 – 15 March 2016, in Madrid, Spain. During the symposium the following presentations will take place:

“Treatment-resistant schizophrenia during life span: epidemiology, outcomes and innovative m-Health treatments within m-RESIST project” by MA Katya Rubinstein (Israel).

“Somatic comorbidity and its outcomes in schizophrenia during lifespan” by MD, PhD Jussi Seppälä (Finland).

E-poster presentation “What do we know about treatment resistant schizophrenia? - A systematic review”, by BSc, med. student Annika Seppälä (Finland).